Table:
begin	end	state
1	37	cytoplasmic
38	60	transmembrane
61	65	non-cytoplasmic
66	89	transmembrane
90	108	cytoplasmic
109	133	transmembrane
134	174	non-cytoplasmic
175	194	transmembrane
195	200	cytoplasmic
201	223	transmembrane
224	244	non-cytoplasmic
245	265	transmembrane
266	281	cytoplasmic
282	305	transmembrane
306	326	non-cytoplasmic
327	350	transmembrane
351	380	cytoplasmic
381	400	transmembrane
401	405	non-cytoplasmic
406	426	transmembrane
427	437	cytoplasmic
438	457	transmembrane
458	462	non-cytoplasmic
463	482	transmembrane
483	492	cytoplasmic

Input:
>N515DRAFT_2924 FitnessBrowser__Dyella79:N515DRAFT_2924
MLKNLFATTQISPASADLPGGGAHGEATLKRALTARHLVLLGIGAIIGAGIFVITGQAAA
EHAGPAIVLSFVFAGIACALAALCYAEFAAMLPVSGSAYSYSYATLGEYVAWFVGWSLVL
EYLFTVATVAAGWSGYFNKLLALISGWIGHDVSLPQTLAAAPFTVVDGHIQATGMFINLP
AVAIIAAITGLCYVGITQSAFVNSIIVAIKVTVILLFIAFATKYINPDNWHPFIPASEGA
SKYGWAGVGRAAAIVFFSYIGFDAVSTAAGEAKNPQRDMPIGIIGSLILCTILYIIVAGI
LTGIADFRLLGTPEPVSTALDNYPSLHWLQIIVVIGAVTGLSSVMLVMLMGQPRIFYSMA
RDGLIPAVFGRIHQKFRTPHVGTVVVGVLAAALGGLFNIGVLGEMVAMGTLLAFATVCIG
VLVLRYTRPELPRAFRVPVPWIVCPLGALACMALFLQSFLEHWRWMLAWIAIGQAIYFLY
GYSHSKLRKPAA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server